🔎 Trials Near Me

Akèy › Ensifizyans kadyak › Kalifòni › Sacramento

Etid klinik pou Ensifizyans kadyak nan Sacramento, CA

12 etid pou Ensifizyans kadyak ap chèche patisipan nan sit nan ak bò kote Sacramento (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • University of California Davis, Sacramento
Laj 30 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT05873634

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

Ap rekriteFaz 3
  • Sutter Institute for Medical Research (SIMR), Sacramento
  • UC Davis Health, Sacramento
Laj 18 a 85 · Tout sèks · Mizajou Sep 24, 2026 · NCT06736574

Alleviant ALLAY-HFrEF Study

Ap rekrite
  • UC Davis Medical Center, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT06812533

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Ap rekriteFaz 3
  • Research Site, Sacramento
Laj 40 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

Ap rekriteFaz 3
  • Sacramento, CA Investigative Site 10024, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06008197

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

Ap rekriteFaz 3
  • CON-10024 Sacramento, CA Investigational Site, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT06024746

NORM-HF Pivotal Study

Ap rekrite
  • UC Davis, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT07574593

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Ap rekriteFaz 3
  • Tenax Investigational Site, Sacramento
Laj 18 a 85 · Tout sèks · Mizajou Aug 19, 2026 · NCT07288398

Alleviant ALLAY-HF Study

Ap rekrite
  • UC Davis Medical Center, Sacramento
Laj 40 ak plis · Tout sèks · Mizajou Aug 14, 2026 · NCT05685303

Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

Ap rekrite
  • Sutter Medical Center, Sacramento
Laj 18 ak plis · Tout sèks · Mizajou Jun 10, 2026 · NCT06526195

Heart Failure Precision Medicine Study

Ap rekrite
  • UC Davis Medical Center, Sacramento
Laj 21 ak plis · Tout sèks · Mizajou Feb 9, 2026 · NCT04196842

Etid Ensifizyans kadyak nan lòt vil

Lòt etid nan Sacramento

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.